# Pharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy Subjects

> **NCT02183376** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 33 (actual)

## Conditions studied

- Hepatic Insufficiency

## Interventions

- **DRUG:** BI 1356

## Key facts

- **NCT ID:** NCT02183376
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-03
- **Final completion:** —
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02183376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02183376, "Pharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02183376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*